SAGE Therapeutics
Develops and delivers novel medicines for most debilitating and disabling central nervous system disorders. Learn more
Launch date
Employees
Market cap
CAD652m
Enterprise valuation
(CAD228m) (Public information from Sep 2024)
Share price
$7.9 SAGE
Raleigh North Carolina (HQ)
Authorizing premium user...